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Abstract: RNA virus genomes are multifunctional entities endowed with conserved structural elements
that control translation, replication and encapsidation, among other processes. The preservation of
these structural RNA elements constraints the genomic sequence variability. The hepatitis C virus
(HCV) genome is a positive, single-stranded RNA molecule with numerous conserved structural
elements that manage different steps during the infection cycle. Their function is ensured by the
association of protein factors, but also by the establishment of complex, active, long-range RNA-RNA
interaction networks-the so-called HCV RNA interactome. This review describes the RNA genome
functions mediated via RNA-RNA contacts, and revisits some canonical ideas regarding the role of
functional high-order structures during the HCV infective cycle. By outlining the roles of long-range
RNA-RNA interactions from translation to virion budding, and the functional domains involved,
this work provides an overview of the HCV genome as a dynamic device that manages the course of
viral infection.
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1. Introduction
The function of RNA molecules is dependent on their sequence, but also on their structure. The
great flexibility and dynamism of RNA folding underlies the versatile features of RNA elements.
RNA structure is maintained by the widespread establishment of hydrogen bonds between different
nucleotides, yielding a set of loops and stems that define the overall folding of the molecule. These help
generate complex conformations, such as helices duplexes, triple-stranded structures and loop-loop
connections. Ultimately, they allow for intricate networks of RNA-RNA interactions, the so-called
interactome, which generates dynamic, high-order RNA structures [1]. These networks of contacts
include both intra- and intermolecular connections, adding a new level of complexity to the architecture
of the RNA genome. The interactions that occur generate different RNA structures that perform tasks
added to the storage of information [2,3]. Understanding RNA folding has, therefore, become an area
of major interest, in which further knowledge is sought on the role of RNA in transcription elongation,
splicing, translation and the synthesis of different protein isoforms, etc. [4].
Viral RNA genomes are compact entities with the capacity to perform different functions during
the infective cycle, as well as carrying protein-coding information. Such genomic plasticity confers
significant adaptive capacity, allowing new hosts and molecular contexts to be explored, thus, promoting
the emergence of new diseases. Given their high mutation rates and population sizes, the evolutionary
capacity of RNA viruses favors the appearance of variants that are resistant to the host immune system
and to treatment. This is achieved by the viral genome, increasing its sequence variation without
disturbing functions essential to the execution of the viral cycle [5]. RNA viruses have evolved to
acquire a supra-coding information system defined by discrete, complexly folded and highly conserved
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RNA structural/functional domains that overlap with the protein-coding sequence. These domains
interact with proteins and other macromolecules, and establish long-distance interactions with other
genomic RNA elements to control the synthesis of viral proteins, the replication of the viral genome,
and its encapsidation [2,3].
Hepatitis C virus (HCV) has been studied as a model member of the genus Hepacivirus, family
Flaviviridae. HCV was discovered three decades ago as the major causal agent of post-transfusion
non-A, non-B hepatitis [6]. From this moment, the rapid emergence of serological and nucleic acid-based
diagnostic tools facilitated the screening of blood samples and the identification of infected patients.
Treatments with direct acting antivirals (DAAs) against viral proteins, either alone or in combination
with pegylated interferon-α and ribavirin, now allow the infection to be controlled, significantly
improving patient prognosis (for a review, see [7]). Further, the recent development of pangenotypic
DAAs is particularly interesting since it provides direct treatment without previous genotype testing.
Despite these advances in therapeutics, many of the molecular mechanisms underlying the control of
the infective cycle remain unknown. For many years, the lack of robust cell culture systems, along with
difficulties in recognizing the actual phase of the life cycle in operation, represented major obstacles to
gaining a complete overview of the infection process. Nowadays, workable replication culture and
infectious systems provide a complete picture [8,9]. Along with these advances, the development
of the “omics” field in molecular biology has led to powerful high-throughput methodologies that
return huge amounts of data from just a single experiment. These advances have filled the gaps in
our knowledge of some virus cycle control systems, and have revealed the importance of long-range
RNA-RNA interactions in the intracellular phase of infection. Further, they have shown that other
RNA viruses, such as flaviviruses [10], or the distant retroviruses [11], share important molecular
features with HCV. Hence, the study of the molecular mechanisms mediated by the HCV RNA genome
has contributed greatly to our understanding of other viral infections.
This review summarizes the major achievements made in our understanding of the HCV genomic
RNA interactome. In particular, recent findings in the field of HCV genomic structure are traced
to define the roles of the alternative conformations of the genomic RNA in the progression of the
intracellular infection. An overview of the participation of the HCV RNA genome in all stages of
the virus life cycle is provided, and the ubiquity of long-range RNA-RNA interactions in other viral
models discussed.
2. The HCV RNA Genome Is a Compact and Resourceful Entity
Like most RNA viruses, HCV is highly variable from a genetic point of view, with eight different
genotypes showing more than 30% nucleotide sequence divergence among them [12,13]. Genotype 1,
with the subtypes 1a and 1b, is the most prevalent variant and the most resistant to treatment and host
defenses, and causes about 40% of infections. These subtypes have been the most studied and used as
molecular models.
The HCV RNA genome is an ~9.6 kb-long, single-stranded, positive RNA molecule, that encodes
a single open reading frame (ORF) flanked by highly conserved untranslated regions (UTR) [6,14,15].
The translation of the ORF generates the structural proteins present in the virions, including the
capsid protein (C), the envelope proteins E1 and E2, and the p7 protein, as well as non-structural
products involved in polyprotein processing (NS2, NS3, NS4A) and replication (NS4B, NS5A and
NS5B) (Figure 1A). The synthesis of an additional viral gene product has been described, also initiating
from the AUG codon (position 342), but with ribosomes shifting at the eleventh codon towards an
alternative reading frame to yield the F protein (Figure 1A) [16–19].
The viral RNA genome is clearly a versatile device. Throughout the genome, structurally preserved
RNA domains form groups of functional and regulatory active regions that play important roles in the
execution of the infective cycle [20–22]. The search for these structural and functional domains has
spanned two decades. By using high-throughput techniques, classical biochemical methodologies, viral
Int. J. Mol. Sci. 2020, 21, 1479 3 of 25
genetics techniques, comparative sequence analyses and bioinformatics strategies, different groups
have provided important information on a large set of structural domains (Figure 1B) [20–23].
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Figure 1. Genetic organization and structurally conserved RNA domains of the hepatitis C virus (HCV)
genome. (A) Diagram showing the genetic organization of the viral genome with the 5′ and 3′ UTRs
are flanking the single open reading frame (ORF). Viral structural and non-structural (NS) proteins and
their functions are indicated. The numbering corresponds to codon positions in the ORF according to
the HCV Con1 isolate, genotype 1b. (B) Diagram of the secondary structure model of the viral RNA
genome. Known conserved secondary structural domains are designated by their names. The color
code and labels at the bottom indicate where each stem-loop is located. The translation starts and stop
codons are marke by arrows.
Some of the most conserved domains, both in sequence and structure, map within the UTRs, the
core c ding sequence, and the 3′ terminus of the ORF (the hypervariable –HV- stem-loop in the 3′UTR
is the most variable lement) (Figure 1B) [20,22,24,25]. The high sequence and structure conservation
ra e suggest th t thes regions hav been preserved sinc the early HCV ancestors of urrent HCV
lin ages [20]. Additionally, many w ll-d fined t uctures have b en identified in the central part of the
genome that does not involve sequence cons rvation (Figure 1B) [20]. Interestingly, these conserved
el ments do not emerge randomly in th ORF; indeed, they are located in precise positions and work to
train g nomic variati n [21–23,25,26]. It has be n suggest d that the preservatio of these element
in well-defined regio s of the HCV gen me facilitates virus persistence by avoiding recognition and
degradation mediat d by RNase L, a innate intracellular antiviral d fense mechanism [27]. RNase L
is a potent endoribonuclease that cleaves ssRNA at UA and UU dinucleotides; it is induced by IFN. It
is noteworthy that HCV RNA genomes corresponding to the most resistant genotypes have a lower
proportion of these dinucleotides compared to variants that are more susceptible to treatment [28]. As
well as protecting against RNase L-mediated degradation, some stem-loops identified in the central
part of the genome have a regulatory function, which they execute by swapping between different
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conformational states [20,22,26]. Therefore, the HCV genome evolves under different pressures to
maintain its compact folding based on short stem loops that can interact with one another to increase
viral fitness.
The genomic sequence not involved in the formation of conserved structures shows significant
variation, a consequence of the high mutation rate associated with the action of the viral RNA
polymerase (nucleotide changes per replication round occur at a rate of ~1 in 10,000 [29]). While this
could have potentially drastic consequences for virus survival, it has been demonstrated that, on
average, only around 10% of the genomic sequence is subject to positive selection. Many studies have
reported extensive positive selection to operate only on the E1, E2 and NS5A genes [30,31]. The increase
in the mutation rate at these locations correlates perfectly with the important role of their corresponding
protein products in the viral response to the host immune system and to therapeutic agents, thus,
favoring the emergence of viral variants and the persistence of the infection [32,33]. Further, high
mutation rates agree perfectly with the ability of HCV to diversify in infected patients [33].
3. The hepacivirus Life Cycle
The HCV life cycle is only partially understood, due to the absence of suitably robust cell culture
and in vivo infection models. In addition, the complex network of surface receptors involved in
efficient viral internalization has delayed the complete understanding of many different molecular
aspects of the HCV intracellular cycle. Figure 2 shows the currently accepted model.
The genome in HCV virions is covered by a lipid membrane in which the viral glycoproteins
E1 and E2 are embedded. HCV particles associated with neutral lipids and apolipoproteins in the
bloodstream, which helps in cell selection and attachment during virus entry [34]. HCV internalization
is a complex, multistep event regulated by numerous interactions involving the glycoproteins E1 and
E2, and by different cellular receptors [35]. Following attachment to liver cells, the viral particles are
internalized via the clathrin-mediated endocytic pathway.
Upon entry, the disruption of the capsid in the endosome allows for the release of the RNA
genome into the cytoplasm. Here, the viral RNA is translated to yield a single polypeptide that
is co- and post-translationally processed by cellular and viral proteases to generate structural and
non-structural (NS) proteins [36] (Figure 2). Most of the NS proteins associated with the endoplasmic
reticulum membranes to constitute the membranous web required for the formation of the replication
complex [37]. The positive RNA genome serves as a template for the synthesis of the negative strand
via the action of RNA-dependent RNA polymerase, which is encoded by the NS5B gene. Interestingly,
the negative strand remains base-paired with its template and can be detected in the cytoplasm of
infected cells in very small amounts. The resulting dsRNA, the so-called replicative form, is then
amplified in a semiconservative and asymmetric manner to generate five to ten-fold molar excess of the
positive stranded RNA progeny [38]. This progeny is devoted to new rounds of translation-replication,
or packaged into new viral particles that are released into the extracellular medium (for a review,
see [7]).
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i r 2. Long-range RNA-RNA interactions and RNA structural domains control the HCV intracellular
cycle. The figure shows a model of the viral cyc e, outlining the participatio of functional gen mic
domains and the RNA-RNA interactome in every step. Briefly, following the recognition of the viral
envelope proteins by receptors n the hepatocyte surface, entry occurs by cla hrin-mediated endocytosis.
The endosome membrane and the viral envelope fuse and the capsid become disorganized (unco ting)
- a proc ss that requires the low pH of the ndosom interior. The genomic RNA is directly translated
on the surface of the endoplasmic reticulum (ER) in an IRES- e endent manner. IRES subdomain
IIId is occupied by the 40S ribosomal subunit, im e ing the interaction IIId-5BSL3.2, but favoring
the contact 5BSL3.2-3′SL2. The interaction established between IRES domains II and IV provides a
optimal structural environment for the correct positioning of the translation start codon. The translation
is enhanced by the acquisition of a circular isoform mediated by the oligomerization of PTB which
binds to the IRES and the 3′X tail. The synthesized polyprotein is co- and post-translationally processed
to generate all the viral factors required for replication. Switching from translation to replication
requires the formation of a closed-loop conformation mainly dependent on long-range RNA-RNA
interactions: Domain II-SL8523; domain II-3′SL2′ and subdomain IIId-5BSL3.2. These contacts promote
a translationally repressed-state and enhance replication via the recruitment of the NS5B viral polymerase
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and the 40S subunit to the functional region at the 3′ of the ORF. Viral RNA synthesis occurs in the
replication complexes on the surface of the endoplasmic reticulum; this requires multiple RNA domains,
but also important conformational rearrangements at the 3′X promoted by the interaction 5BSL3.2-Alt.
This contact induces a structure at the 3′ end of the viral genome that is susceptible to forming genomic
dimers, an optimum substrate for the NS5B protein. Finally, encapsidation requires multiple stem-loops
that work in a cooperative manner to ensure the packaging of full-length, intact viral RNA genomes.
This process occurs in the ER and in the Golgi apparatus, yielding mature virions that are released to
the extracellular medium by conventional exocytosis.
4. Translation in HCV Requires Functional Genomic Domains
Since the virion bears only a single positive strand RNA genome, translation is the first step to be
accomplished during the intracellular phase. Viral protein synthesis depends on the cell machinery, but
it is initiated by a cap-independent, non-canonical pathway that involves an internal ribosome entry
site (IRES) (Figure 2) [39]. The HCV IRES is a structurally unique element that uses dynamic RNA
domains as scaffolds for the recruitment of the translation machinery, minimizing the requirements of
protein factors. Thus, the IRES helps to bypass the canonical cap-mediated screening control to reduce
the cellular response to infection.
The most widely accepted model of HCV IRES-mediated translation initiation can be divided into
three well-defined steps [40,41]. In the first, the IRES directly binds the 40S particle via a high-affinity
mechanism to yield the binary complex [42,43]. Secondly, this binary complex recruits the eIF3 and the
Met-tRNAiMet-eIF2-GTP ternary complex to generate the 48S pre-initiation complex [44–47]. It should
be noted that eIF3-IRES binding is a decoy tool to displace the eIF3 from the canonical 43S pre-initiation
translation complex, thus, releasing the IRES binding site in the 40S ribosomal subunit [48]. Therefore,
it is not essential for the initiation of viral translation per se. Finally, initiation is completed by the
joining of the 60S subunit promoted by GTP hydrolysis, which depends on eIF5B, and the dissociation
of the above factors from the pre-initiation translation complex [49]. Importantly, and in a manner
similar to the canonical initiation and elongation steps, Met-tRNA must base pair with the translation
start codon in the P site [49].
HCV can adapt to different cellular stress situations to overcome eIF2 inactivation or increases
in Mg2+ concentration [50–53]. This is achieved by reducing the need for translation initiation
factors, while the assembly of the 40S and the 60S subunits is still preserved [54]. Alternatively,
the HCV IRES binds directly to pre-assembled translation pre-initiation complexes and induces a
conformational remodeling to accommodate the system to its own needs [53]. Thus, HCV IRES is a
heterogeneous, conformationally complex element, which might explain the virus’ adaptability to the
cellular conditions it encounters.
The IRES maps within the 5′UTR and also spans a short stretch of the coding sequence
(Figure 3) [39,43,55,56]. Although the secondary structure of the IRES has been extensively studied for
two decades, high-resolution structural analyses have recently defined its three-dimensional folding
in the absence and presence of the 40S subunit, providing new insights into how RNA folding may
reduce the need for translation initiation factors [57–62]; the next section explores this further.
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Figure 3. The HCV IRES element. S qu nce and secondary str cture of the 5′UTR in the HCV genome,
including the minimal internal ribosome entry site (IRES). i s i l e in the interaction with eIF3
and the 40S ribos mal sub nit are marked in green a d orange respectively. Potential interaction sites of
ribosomal proteins S14 and S16, depicted as blue ovals, are indicated with arrows. The translation start
codon is revealed in enlarged blue lettering. An alternative folding state of subdomain IIId is shown,
mediated by the slight displacement of five nucleotides that promotes a significant rearrangement at
the base of domain III. PK, pseudoknot. Numbering corresponds to nucleotide positions of HCV Con1
isolate, genotype 1b.
4.1. Functional RNA Domains Required for Binary Complex Formation
The first step of viral translation requires the direct recognition of the 40S subunit. Under
physiological magnesium conditions (~0.5 mM) [63,64], the HCV IRES region binds to the 40S
ribosomal subunit [64]. This binding is directed by a stable and specific tertiary structure defined by
two major and coaxially stacked extended domains - domains II and III - which are organized around
a compact double-pseudoknot element (PK1 and PK2; Figure 3) [57,60,65].
Using a combination of structure probing in solution, cryo-electron microscopy, molecular
dynamics and bioinformatics modelling, different authors have observed that the formation of the
binary complex depends on direct interaction between subdomain IIId, within the IRES, and 18S
rRNA [48,58,66,67]. Subdomain IIId maps within the highly branched domain III of the IRES and is
phylogenetically conserved from a sequence and structural point of view [25,68]. It is a 27 nt-long
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hairpin, with the stem interrupted by an asymmetric internal E-loop, and is capped by a hexanucleotide
loop (Figure 3). The E-loop structure is conserved among different isolates, and its stability depends on
the formation of AA/AG pairs and a reverse Hoogsteen interaction [69]. In nuclear magnetic resonance
analyses, the apical loop appears as a disordered region in which the 5′ side is stacked, while the 3′ side
is exposed to the solvent to generate a backbone reversion known as a U-turn [69]. This conformation
creates an exceptional structural and sequence environment essential for the formation of the IRES-40S
complex [48,64,66,67,69]. In fact, binding to the 40S subunit depends on RNA-RNA interactions
involving the phylogenetically conserved GGG triplet within the apical loop of subdomain IIId, and
the complementary CCC triplet of helix 26 in the 18S rRNA [48,58,66,67]. The essential role of the apical
loop of subdomain IIId in virus survival, therefore, relies on this interaction. This idea fits perfectly
with the results of phylogenetic and functional studies that show that mutations in the apical loop
drastically reduce IRES activity in vitro and in cell culture [41,68,70–72]. In addition, the apical loop of
subdomain IIId might be related to differential responses to interferon treatment, although additional
factors might contribute to the outcome of therapy [72]. The molecular mechanisms underlying the
activity of IIId may, therefore, be based on the combination of both protein and RNA recruitment,
suggesting subdomain IIId to be an important element in the HCV interactome. Together, these results
reinforce the importance of sequence and structure preservation in assessing the biological role of
subdomain IIId, and make it a tempting therapeutic target [73].
Domain II of the IRES also plays an important role as a conformational manager in the constitution
of the IRES-40S binary complex [74]. This domain contacts with the 40S subunit over the decoding
groove, promoting changes in its structure in a manner similar to those induced by eIF1 and eIF1A in
the canonical eukaryotic translation model [61,62,74,75]. Domain II folds into a distorted stem-loop
with an L-shape, a consequence of the presence of the internal E-loop (Figure 3) [76,77]. This E-loop
creates a bend that separates the basal stem IIa and the apical stem-loop IIb, which directly contacts
with ribosomal proteins S14 and S16 [78] at the interface between the 40S and 60S particles in the
mRNA binding cleft. When bound to the 40S subunit, a complex four-way junction defined by the
double-pseudoknot organizes domains II and III in a coaxial manner [46]. In this conformation, domain
III binds to the solvent side of the 40S particle, while domain II reaches the interface cleft and the E-site
of the ribosome, leading to a rotation of the ribosomal head and the consequent opening of the mRNA
entry channel [57,74,79]. Such a structural organization is also managed by the coordinated action of
long-range interactions within domains of the IRES. These interactions mainly involve domains II and
IV (a short stem-loop containing the AUG codon) (Figures 3 and 4) [80,81]. Thus, subdomain IIb favors
the unwinding of domain IV to accommodate it within the 40S decoding groove, efficiently initiating
viral translation [46].
4.2. Structural Basis for the Recognition of eIFs by the HCV IRES
The constitution of the 48S complex requires the recruitment of eIF2 and eIF3 to the IRES-40S
complex [82].
eIF3 specifically recognizes the apical portion of domain III, involving the subdomains IIIa, IIIb and
IIIc (Figures 2 and 3) [83]. These subdomains are organized into a four-way junction that operates as a
platform for factor association [47,69,83,84]. Interestingly, this region of the IRES accumulates a certain
degree of sequence variation, rendering viral variants with different translational efficiencies [85]. This
finding supports the evidence that the association of eIF3 is not essential for viral protein synthesis [48].
In addition, the bond between the IRES and eIF3 is weaker than that between the IRES and the
40S subunit [40], favoring the chances of domain III positioning itself correctly in the pre-initiation
complex [48]. The association or release of eIF3 by the IRES can be conditioned, at least in part, by
the local flexibility of the GC-rich stem within subdomain IIIb (Figure 3) [83,86]. This subdomain
is composed of a long stem, which is interrupted by a conserved CC mismatch and the variable
internal loop, and closed by a large and heterogeneous apical loop. As revealed by mutagenesis
studies, the preservation of the sequence within the apical loop is not essential for IRES activity, but it
Int. J. Mol. Sci. 2020, 21, 1479 9 of 25
could influence different mechanisms of translation control [87,88], reinforcing the role of the IRES
three-dimensional structure as the main control element during translation initiation.
4.3. Dynamic Conformational Tuning of the Translationally Active 80S Complex Mediated by IRES Domains
Different high resolution microscopy studies have provided a dynamic view of the IRES-80S
complex [61,62]. The recruitment of the 60S particle requires the conformational rearrangement
of the 40S subunit, not only in terms of the ribosomal proteins, but also of the 18S rRNA [58,61].
These rearrangements are reverted when tRNAi occupies the P site. The reversion is coincident
with a structural reorientation of domain II [62]. Thus, domain II moves out of the E site to allow
for the incoming deacylated tRNA from the P site. As a consequence of these reorientation events,
eIF5-dependent eIF2-GTP hydrolysis is activated. The translation pre-initiation factors are then released
from the ribonucleoprotein complex, and the productive translation initiation complex is constituted.
Translation initiation in HCV is, thus, a dynamic and highly controlled process dependent on
structural units that operate in a coordinated fashion. Such dynamism may also favor the existence of
different pathways for overcoming adverse environmental conditions.
4.4. Translational Enhancement Mediated by cis-acting RNA Elements and Long Range RNA-RNA Contacts
High-order RNA structures affect translation initiation, elongation and termination. In particular,
mRNA circularization increases translational efficiency by encouraging ribosome recycling and
providing protection against the action of exonucleases [89]. In viral RNA genomes, the acquisition of a
closed-loop conformation and the establishment of long-range interactions between different functional
genomic domains work as efficient and flexible managers of multiple stages of the intracellular
virus cycle.
HCV RNA has acquired a sophisticated translational control system. The molecular mechanism
involves three differently evolved functional regions (Figures 2 and 4A): (i) Subdomain IIId and the
core double-pseudoknot in the IRES (the role of the latter in viral protein synthesis has already been
detailed); (ii) domain 5BSL3.2 at the 3′ end of the ORF; and (iii) the 3′X-tail at the very 3′ end of the
HCV RNA genome.
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structural units that operate in a coordinated fashion. Such dynamism may also favor the existence 
of different pathways for overcoming adverse environmental conditions.  
4.4. Translational enhancement mediated by cis-acting RNA elements and long range RNA-RNA contacts 
High-order RNA structures affect translation initiation, elongation and termination. In 
particular, mRNA circularization increases translational efficiency by encouraging ribosome 
recycling and providing protection against the action of exonucleases [89]. In viral RNA genomes, 
the acquisition of a closed-loop conformation and the establishment of long-range interactions 
between different functional genomic domains work as efficient and flexible managers of multiple 
stages of the intracellular virus cycle.  
HCV RNA has acquired a sophisticated translational control system. The molecular mechanism 
involves three differently evolved functional regions (Figures 2 and 4A): (i) Subdomain IIId and the 
core double-pseudoknot in the IRES (the role of the latter in viral protein synthesis has already been 
detailed); (ii) domain 5BSL3.2 at the 3′ end of the ORF; and (iii) the 3′X-tail at the very 3′ end of the 
HCV RNA genome. 
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Their roles for different steps of the viral cycle – translation (A), replication (C) and transitions between
them (B), as well as RNA genome packaging (D) – have been proposed.
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The acquisition of a circular isoform by the HCV genome during translation initiation is enhanced
by the likely oligomerization of the polypyrimidine tract-binding (PTB) protein, which binds to both
the IRES and the 3′X tail [89–91]. Furthermore, proteins might be involved in this process [92,93].
The 3′X directly recruits different ribosomal components and the eIF3 protein (Figure 2) [93,94],
supporting a model in which translational enhancement occurs in cis via the transfer of the translation
machinery from the 3′ end of the genome to the IRES, especially during the termination stage of each
translation round.
The 3′X tail - a 98 nt-long region showing strong sequence and structure conservation (Figure 5) -
was identified almost simultaneously by different groups [95,96]. The fact that only a single substitutions
in the 3′ terminal region have been detected suggests it has an important function in the infective
cycle [96]. From a structural point of view, the 3′X element shows dynamic behavior by adopting
two major and mutually exclusive conformations of similar thermodynamic stability (Figure 5). Both
isoforms preserve the 3′SL1 stem loop at the very 3′ end of the viral genome, while the 55 nt-long
upstream region changes from two stem-loops (3′SL3 and 3′SL2) to a single, extended stem-loop, i.e.,
3′SL2′. The latter exposes a palindromic nucleotide sequence (dimer linkage sequence, DLS) in the
apical-loop (Figure 5) [90,97–99]. It has been suggested that the switch between conformations may
be related to differential ligand (protein and RNA) affinity. In fact, the binding of the PTB protein,
ribosomal components and eIF3 seems to occur largely at 3′SL2, suggesting that the three stem-loop
isoform may operate as a regulatory element at the translational level [90,93].
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A long-range RNA-RNA interaction that seems to be required for efficient HCV translation has 
also been reported (Figure 2) [100]. This interaction involves the k-motif in 3′SL2 in the 3′X tail, and 
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A long-range RNA-RNA interaction that seems to be required for efficient HCV translation has
also been reported (Figure 2) [100]. This interaction involves the k-motif in 3′SL2 in the 3′X tail, and
the complementary nucleotide sequence k’ in the upstream 5BSL3.2 domain [99,101–104], yielding a
dynamic pseudoknot structure (Figures 4A and 5) [104]. Domain 5BSL3.2 is located at the 3′ end of the
ORF within the NS5B coding sequence; it is a 48 nt-long imperfect stem-loop with a 12 nt-long apical
loop (Figure 5) and an 8 nt-long bulge interrupting the duplex [102,103,105]. Both unpaired regions
within this domain are phylogenetically conserved across different genotypes [102], suggesting their
participation in the establishment of interactions with other regions of the viral genome [106]. The
acquisition of a closed-loop conformation defined by the specific contact 5BSL3.2-3′SL2 seems to be
essential for the enhancement of translation, most likely by inducing the opening of 3′SL2 [100,104].
This might favor the recruitment of factors required by the cell translational machinery. Abolishing the
5BSL3.2-3′SL2 contact reduces translation [100]. This regulatory mechanism gains further relevance
in the light of results showing that the contact 5BSL3.2-3′X occurs in the absence of RNA chaperone
proteins and even in the two stem-loop conformation of the 3′X, in which the k motif is partially
occluded in the stem of 3′SL2 (Figure 5) [107]. This points to domain 5BSL3.2 acting as a structural
cofactor that promotes the conformational rearrangement of the 3′ end of the viral genome. The
described regulatory system, thus, has a riboswitch-like mode of action which, depending on the
presence of specific ligands or external stimuli, allows for two mutually exclusive metastable structural
states. This device ensures that adequate viral protein levels are in place before the replication and
encapsidation steps begin.
5. From Translation to Replication. The Role of HCV RNA Circularization
HCV replicates in the cytoplasm once viral protein levels are adequate. Actively translating
viral RNA molecules must be transferred to the replication complexes, which contain non-structural
viral proteins embedded in the endoplasmic reticulum. This supramolecular complex generates a
membranous web that provides a suitable microenvironment for replication [108,109]. In the replication
complexes, positive ssRNA acts as a template for the synthesis of the full length negative ssRNA
intermediates required to generate the positive ssRNA genomes for use in new rounds of translation,
replication and virion packaging. Since RNA replication has to initiate from the 3′- end of the RNA
template, this region accumulates numerous functional domains that participate not only in translation
(see above), but also in replication control.
The molecular mechanisms underlying the switch from translation to replication in HCV are
largely still only hypotheses. Plausible proposals involve the participation of genomic domains acting
in cis, both as binding platforms for cellular and viral proteins and as organizers of long-distance
RNA-RNA contacts (Figures 2 and 4B).
The recruitment of viral NS5B polymerase by the 5BSL3.2 domain has been reported, [110],
presumably to form the replication complex in combination with other non-structural HCV proteins
and cellular factors, such as ribosome components [111]. The demonstrated ability of NS5B to
bind ribosomes reflects the mechanism used by Qβ virus to build its own replication system [111].
Interestingly, the ribosome bound-NS5B forms are highly active in RNA replication [112]. From
a functional and physical point of view, both NS5B and ribosomes are associated via the highly
conserved domains 5BSL3.1 and 5BSL3.3 that flank the 5BSL3.2 domain (Figure 5) [113]. Domains
5BSL3.1, 5BSL3.2, and 5BSL3.3 define an element located at the 3′ end of the ORF with regulatory
roles in translation (as mentioned above), and replication [102,105,114]. Together they compose a
cis-acting replication element (CRE) [102,105]. The CRE efficiently and specifically binds the human
40S ribosomal subunit, mainly at 5BSL3.1 and 5BSL3.3. This, along with the association of NS5B to
5BSL3.2, highlights the critical role of these domains in controlling the switch from translation to
replication [113]. The balance between different functionalities performed by these three domains is
achieved by preserving the proper conformational equilibrium. 5BSL3.1, 5BSL3.2, and 5BSL3.3 fold
into a high-order, cruciform structure with dynamic properties [102], that promote the switch between
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different metastable structural states in the RNA molecule by virtue of different external stimuli. This
renders domains 5BSL3.1, 5BSL3.2, and 5BSL3.3 organizers and regulators of replication initiation.
During translation, viral genome circularization mainly accounts for the establishment of protein
bridges between both ends of the RNA. In the early steps of replication, the virus takes advantage of
the different structural elements at either end of the RNA molecule to promote this circular isoform.
Its acquisition is the initiation signal for viral HCV RNA synthesis (providing further proof of the
versatility of viral RNA genomes). In HCV, indirect evidence suggests the existence of two long-range
RNA-RNA contacts involving different functional domains that promote the formation of a closed-loop
conformation (for a review, see [3]).
Our group provided the first evidence of HCV RNA circularization mediated by RNA-RNA
contacts in 2009 [115]. We showed that the bulge of the 5BSL3.2 at the 3′ end of the ORF directly
interacts with the apical loop of subdomain IIId within the IRES (Figure 4B). This interaction is stable in
the absence of protein factors and induces conformational changes, not only in the directly interacting
regions, but also in other distant elements of the viral genome, as demonstrated in replication competent
RNA transcripts [86,116]. In subdomain IIId, the residues at the apical loop may appear partially
occluded and non-accessible to the surrounding solvent because of the interaction with domain
5BSL3.2 [117]. This alternative structure may reduce the affinity of the IRES for the 40S subunit,
promoting the escape of the ribosome from the IRES and impeding translation initiation. Structural
tuning of subdomain IIId has also been reported by other authors [21]. Fricke et al. described that the
stem-loop IIId swings and extends 5 nt downstream, displacing the position of the apical loop, which
appears as an extension of the stem (Figure 3) [21]. The displacement of the trinucleotide GGG from
the apical loop to the stem would lead to less efficiently translated viral genomes by impeding the
proper interaction with 18S rRNA [67,118]. This alternative structure could coexist with the previously
validated conformation. Additional efforts are required to discover the triggering stimuli that promote
the acquisition of each.
The contact IIId-5BSL3.2 also induces a rearrangement event in the 3′X tail, favoring the two
stem-loop conformation (Figures 2, 4B and 5) [116]. Such a structure is associated with reduced
translation efficiency [100]. This supports the model in which the interaction between subdomain IIId
and the 5BSL3.2 domain interferes with efficient viral protein synthesis, thus, favoring the initiation of
the replication step [114]. The model is confirmed by the observation that nucleotides located in the bulge
of the 5BSL3.2 domain specifically and efficiently interfere with HCV IRES-dependent translation [114].
This strongly contrasts with the hypothesis proposing that 5BSL3.2 is required for viral protein
synthesis (see above). It is noteworthy that the mechanism by which the 5BSL3.2 domain switches from
translation enhancer to translation inhibitor depends on long-range RNA-RNA interactions, either
with the 3′X tail or the subdomain IIId. These contacts are established in an independent manner and
may be promoted by different factors [104,106,119] that induce conformational rearrangements in the
involved regions.
HCV RNA circularization during viral replication is also stabilized by the long-range interaction
established between the apical loop of domain II in the IRES, and the DLS motif in the 3′X region
(Figures 2 and 4B) [21]. In the theoretical model proposed, the initial interaction would span 62 base
pairs, although this would require the (unlikely) complete unfolding of domains I and II of the IRES,
together with the destabilization of the 3′X tail. Recent studies have suggested the participation of
residues 95-110, which overlap with the bulge of subdomain IIb in the IRES, in a long-range RNA-RNA
interaction with positions 8528-8543 in the NS5B coding sequence region (which is rich in stem-loop
domains) (Figures 2 and 4B) [120]. Interestingly, the flexible bulge of subdomain IIb takes part in the
translation-to-replication switch [121], but in addition acts as moderate replication repressor [122],
suggesting a new regulatory function for this long-range interaction. Both interacting motifs, 95-110
and 8528-8543, are structurally inaccessible; therefore, the destabilisation of both stem-loops is required
for an efficient interaction to occur. Since the interaction IIId-5BSL3.2 induces fine-structural tuning to
different regions of the HCV genome [86,116], it seems likely that it should operate as an initial contact
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to promote further conformational rearrangements leading to the stabilization of other long-range
interactions required to achieve the circularization of the viral genome needed for replication control.
These observations, along with the fact that the interaction IIId-5BSL3.2 is a negative regulator of HCV
translation, suggest that viral genome circularization is a complex and coordinated process mediated
by long-range RNA-RNA interactions and stabilized by the participation of different cellular and
viral factors. Together, these create the proper environment for the initiation and regulation of HCV
RNA synthesis.
6. Viral RNA Synthesis Is Controlled by High-Order Structures of the Genomic RNA
The control of HCV replication was associated with the 3′UTR for a long time. However, it is now
known that the 5′UTR and the coding region contain important elements for viral RNA production
(Figures 2 and 4C).
In addition to the evident role of the 5′UTR in viral translation, it promotes a significant
enhancement of replication efficiency. Domains I and II at the very 5′ terminus of the HCV genome
(Figure 3) are indispensable for RNA synthesis [123,124]. However, it is uncertain whether this activity
relays on these domains of the positive or the negative strand, or both. The molecular mechanism by
which the 5′UTR participates in RNA synthesis is also unknown. The specific recruitment of different
protein and RNA factors [125], as well as the structural preservation of different signals involved in
replication, are tempting hypotheses [118].
In the core coding region, the preservation of the conserved stem-loop SL588 is essential for
efficient replication, pointing to this domain as a cis-acting replication domain (Figures 2 and 4C) [22].
Although the mechanism by which this element works has not been experimentally validated, its
involvement in a long-range interaction with the apical loop of the conserved SL427 has been proposed
(Figure 4C). This again highlights the importance of RNA-RNA interactions in the control of the
HCV cycle.
HCV replication requires the binding of the NS5B protein to the 5BSL3.2 domain, a process favored
by the locally high concentration of the NS5B protein and the RNA genome [110,126]. The question
remains as to how the 5BSL3.2 domain moves to recruit NS5B from interacting with subdomain IIId in
the circular isoform. Again, long-range RNA-RNA contacts might provide an efficient mechanism.
A highly conserved sequence motif named Alt was identified upstream of the 5BSL3.2 domain
(Figure 4B) [127]. This sequence locates to the base of the stem-loop named 9110 and can base pair with
the bulge of 5BSL3.2 (Figure 4C) [106,127]. The interaction promotes a conformational rearrangement
at the 3′X tail toward the two stem-loop isoform, leaving a 3 nt overhang at the 3′ end of 3′SL1, which
emerges via a slight displacement to generate the so-called 3′SL1′ (Figure 5) [99,107]. This folding
state provides an appropriate environment for virus replication [128]. It should be noted that this
Alt-5BSL3.2 contact overlaps with that involving subdomain IIId. Both interactions show constant
dissociation values in the same range, and seem equally likely to occur [106]. Further, they are assumed
to show an additive and enhancing effect on RNA replication by promoting a repressed translational
state in the viral RNA (interaction IIId-5BSL3.2) and subsequently favoring the recruitment of the
NS5B protein (interaction Alt-5BSL3.2). It seems likely that transitions between both contacts are
influenced by additional, non-reported structural constraints and the presence of different cofactors. In
this context, the specific binding of viral and cellular proteins to the 5BSL3.2 domain is well reported
and may underlie the intricate mechanism that regulates viral RNA production [129–133].
The NS4B coding region also contains tools for the control of RNA replication (see Figures 2 and
4C) [22]. For example, a functional domain named SL6038 has been described which can adopt two
conformations: a cloverleaf-like structure that activates viral RNA synthesis, and a stem-loop isoform
that interferes with the replication [22]. Similarly, stem-loop SL8001 in the NS5B coding region has
been proposed to be a replication control device via its mediating conformational tuning events.
Besides its involvement in intramolecular interactions, the HCV RNA genome can take part in
intermolecular contacts via the formation of genomic homodimeric particles with structurally unusual
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features, and in the absence of any protein factors (Figures 4C and 5) [98]. Dimer formation in HCV
is dependent on the palindromic DLS motif (Figure 5), which operates as a starting signal for the
formation of a kissing complex involving the nucleotides exposed in the loops [98]. The initial complex
can evolve, under certain conditions, towards an extended duplex conformation involving the whole
DLS motif [119]. As a consequence, the 3′SL1 domain refolds to 3′SL1′, creating the optimal structural
environment for NS5B activity [134].
Distant genomic regions influence HCV dimer formation efficiency. Dimer formation is controlled
by the CRE at the 3′ end of the ORF (i.e., 5BSL3.1, 5BSL3.2, and 5BSL3.3), which improves the
dimerization yield, and by the IRES at the 5′ end, which exerts an inhibitory effect on dimerization even
in the presence of enhancer elements [135]. The high conservation rate of both the IRES and the CRE,
and their essential roles in translation and replication, suggest that dimerization is critical for virus
propagation. These observations confirm the strong influence of the CRE region (particularly 5BSL3.2)
in the regulation of different steps of the viral cycle via its participation in the establishment of a
complex network of contacts. Moreover, the latter work supported previously collected data suggesting
that undiscovered IRES-3′X contacts [21,116] help in the acquisition of the closed-loop conformation
during the replication step. In fact, this conformation would be preserved even in the negative strand
since these interactions are predicted to take place as well, pointing to genome circularization mediated
by distant RNA-RNA contacts as the core molecular mechanism in the regulation of the viral cycle,
including the switching between events.
7. RNA Elements also Control Viral RNA Packaging
Virion assembly in HCV is a complex process that relies strongly on the interaction of the RNA
genome with the capsid - or core - protein. It also requires the coordinated action of viral proteins
and host factors (for a review, see [136]). To date, all the non-structural viral proteins have been
shown to contribute to this process, though the mechanism by which virion assembly occurs remains
elusive. The development of new virus culture systems in recent years has provided new evidence on
the mechanism involved in the incorporation of viral genomes into new virions, but the full picture
remains unclear.
The HCV assembly process appears to be spatially associated with lipid droplets, to which the
core protein is linked [137]. Interaction with the RNA genome requires a structural signal, located at
the 3′ end of the viral genome, which is recognized by specific domains of the core protein (Figures 2
and 4D). This mechanism ensures the incorporation of full-length genomes only [138]; no packaging of
replication-defective HCV genomes can take place. The maintenance of the structural signal at the 3′
terminus, either via viral NS3 helicase [139] or by preserving the proper balance between different
RNA-RNA interactions [3,26], is therefore, indispensable for correct encapsidation. In this context,
it is noteworthy that the 5BSL3.2 domain diminishes the affinity of the 3′UTR for the core protein,
confirming previous observations that point to a conformational rearrangement at the 3′ end of the viral
genome mediated by the interaction 5BSL3.2-3′X [99,100,104,107,116,135]. Hence, the preservation of
the structure at the 3′X tail for successful viral packaging is likely to prevent its interaction with the
5BSL3.2 domain. Again, the HCV genome takes advantage of its complex folding to create dynamic
interaction networks that can displace the equilibrium towards the desired step of the infective cycle.
For example, the element SL8670 [20], which is involved in virus production, but not in RNA synthesis,
is predicted to interact with a part of the DLS motif [26], suggesting a control mechanism for RNA
packaging (Figures 2 and 4D).
The 3′X structural signal is not the only actor required for efficient HCV assembly. In contrast to
the many RNA viruses that use large, stable RNA structural elements with high-affinity for the core
protein as the encapsidation signal, HCV seems to takes advantage of multiple domains with low
affinity for the core protein as a means of presenting the intact, full-length genome to the assembly
complex (Figure 4D) [140]. Such domains are dispersed throughout the genome to act in a cooperative
manner. Using a SELEX (systematic evolution of ligands by exponential enrichment) methodology,
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Stewart et al. [141] demonstrated the existence of different conserved stem-loops located in the core
and the non-structural protein-coding sequence that is involved in the packaging (see Figures 2 and
4D). Other authors have also noted different stem-loops in the core and NS5B coding sequences to
be important in virion production [20,22]. The results of the above SELEX analysis also confirmed
the absence of encapsidation signals in the E1 and E2 coding regions [142,143]. All of the identified
stem-loops in combination, but not independently, are required for virion production, though they are
not essential for HCV translation and replication, suggesting them to be specific, cooperative signals
for genome encapsidation. The preservation of folding at precise locations is, therefore, also important
for RNA genome packaging and virion budding [20,22,141].
8. Genome Circularization Strategies in RNA Viruses Mediated by RNA-RNA Contacts
Viral genome circularization is not exclusive to hepaciviruses. Indeed, circular RNAs are
represented in all kingdoms of life. In RNA viruses, however, the ubiquitous circularization process
acquires new importance, acting as a regulatory tool in cis. It is especially important in viruses lacking
the cap structure (e.g., picornaviruses), the polyA tail (e.g., reoviruses) or both (e.g., hepacivirus). In
good agreement with the HCV model, the 5′-3′ end communications in other RNA viruses involve
elements critical for translation and replication, making the closed-loop topology indispensable for
viral fitness. Since translation and replication are mutually exclusive, it is also likely that circular
isoforms operate as elements that manage the transitions between different stages of the viral cycle.
In some cases, such as in polioviruses and reoviruses, RNA genome circularization occurs via a
protein-protein bridge [144,145]. In flaviviruses (e.g., Dengue virus [DENV]) and retroviruses (e.g.,
human immunodeficiency virus [HIV]), however, complementary sequences located at the 5′ and the
3′ ends of the viral genome can base pair to establish a long-range contact. This initial contact can
be further stabilized by the recruitment of viral and/or cellular proteins, but more importantly, via
additional RNA-RNA interactions [12,146,147].
Retroviral replication involves a reverse transcription step with two obligatory DNA strand
transfers; these are needed to generate the complete full-length RNA genome, which is then packaged.
To facilitate these strand transfer events, the virus uses RNA circularization dependent on RNA-RNA
interactions [12,148]. In HIV-1, one of the most studied models, several interactions have been proposed
to participate in the acquisition of a closed-loop conformation (Figure 6A). One involves a palindromic
sequence motif in the TAR element. The TAR hairpin is a highly conserved domain with an essential
role in viral replication. Since it is located at both ends of the viral genome, it is thought to mediate
direct circularization. The other interaction connects sequence motifs in the gag gene at the 5′ end
of the open reading frame with the 3′ terminal U3R region [12,148]. In both cases, it is important to
note that the elements potentially involved in the circularization of the genome are evolutionarily
conserved across different HIV-1 subtypes, suggesting that the circular isoform is actively used.
Int. J. Mol. Sci. 2020, 21, 1479 17 of 25
















Figure 6. Long-range RNA–RNA contacts in representative RNA viruses with linear genomes. This
figure shows the proposed conserved secondary structural elements and sequence motifs within the 5′
and 3′ ends of retroviruses, such as HIV-1 (A) and DENV-2 (representative of flaviviruses) (B) involved
in genome circularization. The ORF and the UTRs (RU5 and U3R for retroviruses) are indicated. Thin
colored lines denote long-distance RNA–RNA interactions between genomic termini. The pseudoknot
elements (PK1, PK2, and PK3) are indicated by dashed black lines.
In flaviviruses, end-to-end genome connections rely on at least three specific interactions involving
complementary sequence motifs located at essential domains at both ends of the viral RNA (Figure 6B).
The pairs of nucleotide motifs include the so-called CYC element, the UAR pair, and the DAR sequence
motifs (for a review, see [10]). These pairs are established in a sequential manner, allowing for
cooperative and efficient formation of the closed loop, which is then stabilized by the recruitment of
different host factors to improve the final yield [10]. Though low conservation rates have been reported
for some of the sequences involved, the cyclization process is a universal and essential event among
flaviviruses [149,150].
This brief overview reflects the universality of the circularization process in RNA viruses and its
value in controlling the viral cycle. It is noteworthy that circular isoforms emerge under certain stimuli
and may coexist with the linear form. Preserving the balance between different conformations helps
ensure viral fitness and propagation.
9. Conclusions and Perspectives
Protein coding-information represents only a small portion of the genetic information carried in the
genome. Viral RNA genomes use an information coding system involving structural genomic domains
that overlap the protein-coding system. These domains express their information by establishing a
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dynamic network of long-distance RNA-RNA interactions - the interactome - and the recruitment of
cellular and viral factors. It is this network that governs the execution of the viral cycle. In the case of
the HCV RNA genome, it seems clear that the 5BSL3.2 structural domain within the CRE, located at the
3′ end of the ORF, plays a central role in the management of the RNA-RNA interactome, and therefore,
in the fine regulation of the viral cycle. During the early phase of infection, the RNA genome mainly
functions as mRNA, and is therefore, dedicated to translation. However, the recruitment of viral RNA
polymerase by the structural domains at the 3′ end of the genome, and the consequent modification of
RNA-RNA interactions, leads 5BSL3.2 to repress IRES translation initiation. The 5BSL3.2 domain also
promotes replication, increasing the number of viral genomes and favoring the formation of genomic
RNA dimers. These replication competent-conformers remain, however, incompetent for packaging.
The dissociation of the dimers yields competent forms for translation and consequent packaging.
Exploring the interactome of other related RNA viruses and their functionality should provide
further information on the regulation of the viral cycle and provide a means of identifying potential
targets for the development of antiviral strategies. It should be anticipated that the lack of structural
RNA domain conservation among different viruses means that different RNA viruses, even when
closely related, will use different strategies involving different RNA domains to achieve the goal of
regulating the essential steps of their infective cycle.
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